The Erythropoietin/Erythropoietin Receptor Signaling Pathway Promotes Growth and Invasion Abilities in Human Renal Carcinoma Cells
Co-expression of erythropoietin (Epo) and erythropoietin receptor (EpoR) has been found in various non-hematopoietic cancers including hereditary and sporadic renal cell carcinomas (RCC), but the Epo/EpoR autocrine and paracrine mechanisms in tumor progression have not yet been identified. In this s...
Main Authors: | Wu, Pengjie, Zhang, Ning, Wang, Xi, Zhang, Chi, Li, Teng, Ning, Xianghui, Gong, Kan |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445554/ |
Similar Items
-
Erythropoietin and renal protection
by: Baradaran, Azar, et al.
Published: (2013) -
Functional significance of erythropoietin in renal cell carcinoma
by: Morais, Christudas, et al.
Published: (2013) -
Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma
by: Ribatti, D, et al.
Published: (2007) -
Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo
by: Christensen, Britt, et al.
Published: (2016) -
RHEX in the mix of erythropoietin signaling molecules
by: Broxmeyer, Hal E.
Published: (2014)